about
Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filtersLipocalin 2 (LCN2) Expression in Hepatic Malfunction and TherapyDevelopment of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival.Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysisTechnical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular CarcinomaCirculating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas.Analogous detection of circulating tumor cells using the AccuCyte® -CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer.Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma.Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNANew prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinomaEffect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
P2860
Q26778909-6118B9A7-6F9D-4205-9ED7-EE5DEA5B0202Q28068137-E5B9BC45-D18D-4E6A-A8C2-214402132B46Q30240748-08EE5D17-FAF7-4BFC-BAA9-14FBAF4F401CQ33579810-5B029B39-83BF-479E-9B43-62C49ABAB0EBQ35169325-B9ACF172-8A02-4182-A8FD-FE523EF4F54AQ35775519-713FE68B-FD2B-4DF7-A81C-4ABE8CA293ADQ36242936-8AA1DEDF-8E1F-4C7C-99D1-F5D8867C7415Q36287599-7AD9387C-9E4C-4079-A00D-FC54038B9236Q36532522-51F38272-B1E7-4057-8528-ADC82264074DQ36545829-612C11E8-FB2E-44A1-B389-BCAF921529CAQ38635611-D5682920-3D49-42E5-83D1-0E88FC634735Q39339880-DE8E0C58-A59C-4A9D-81A7-0CB5C668A013Q41191656-0130F28D-0099-4465-8373-9254336E90E4Q41241610-319B2F42-EC67-4E7B-9D65-7A5EADBF0632Q41505555-6B29A222-CE9E-4CF2-8AC2-68FA9E3A10C8Q42378979-26C2AB3B-37B6-45D9-9773-860929B4177CQ47760107-1494F1C3-0AD3-4D4B-A54F-2E5E99BCACEFQ53734327-DF3A5C7B-70BE-4919-9143-702476F635B3Q55023971-E7E92B13-B44B-468A-9055-B35A96DAAFE4Q57161777-D780FD1A-B22D-4378-82C1-46459B788ACDQ57482211-3FC10088-10EA-4A2E-9C7B-2054BAF94280Q58736825-BC8D4C40-370B-4D26-BA7D-6F4534FC869C
P2860
description
article
@en
im Juni 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2014
@uk
name
Circulating biomarkers in hepatocellular carcinoma
@en
Circulating biomarkers in hepatocellular carcinoma
@nl
type
label
Circulating biomarkers in hepatocellular carcinoma
@en
Circulating biomarkers in hepatocellular carcinoma
@nl
prefLabel
Circulating biomarkers in hepatocellular carcinoma
@en
Circulating biomarkers in hepatocellular carcinoma
@nl
P2093
P2860
P50
P1476
Circulating biomarkers in hepatocellular carcinoma
@en
P2093
Atsuhiko Katoh
Clare Hodgson
Debbie Burt
Jonathan D. Tugwood
Juan W. Valle
Karen L. Morris
Leila Khoja
Matthew Lancashire
Takahiro Ishiguro
P2860
P2888
P304
P356
10.1007/S00280-014-2508-7
P577
2014-06-13T00:00:00Z